IN8bio, Inc. (INAB) vs Moleculin Biotech, Inc. (MBRX)
IN8bio, Inc. and Moleculin Biotech, Inc. are both Biotechnology companies. IN8bio, Inc. and Moleculin Biotech, Inc. are of similar size ($11.2M and $11.1M). IN8bio, Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.1×. Across the 9 metrics below, Moleculin Biotech, Inc. leads on 5 and IN8bio, Inc. on 4.
Valuation
Profitability
| Metric | INAB | MBRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (111.11%) | (1,471.05%) | (57.72%) |
| Return on assets | (90.80%) | (152.41%) | (49.22%) |
| Return on invested capital | (2,948.56%) | (417.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack